# Silence Therapeutics aims at Takeda with new data in rare blood cancer

> **Newsylist Open Intelligence Dossier** · First detected: 2026-08-10 20:29 UTC · Category: Business · Sources: 7 · Current Velocity: 4.63

## Multi-Source Evidence Table
| Source Outlet | Headline | Published (UTC) | Verification URL |
|---|---|---|---|
| Pluang | Stocks surge on major acquisition deals and str... | 2026-08-10 11:33 | [Source Link](https://news.google.com/rss/articles/CBMilAFBVV95cUxOZlhnVG1JeHM3OXZwcXNpQmZBQXktT05GRERFQlY3TGFnNHhTcU1TUlNjVWNtbHRWVVVGVkNSNGxBVjdoYzMwa0lmQ3lDTGxMODYzNXl1dDNzNUZ0QnhOdmtBWXFhODZsM0Exd2dzSmdJT1YzemRzaXRhVzhGeEhaVFlndEZhQ1pkYVYzLWk5UzBlR240?oc=5) |
| Cure Today | Divesiran Eliminates Need for Phlebotomy in 88% of Patients With Polycythemia Vera | 2026-08-10 11:33 | [Source Link](https://news.google.com/rss/articles/CBMisgFBVV95cUxPR1h5Y1VrTG4zZnNXSmhRWXBQTDEyUjdoa2UxeHFzNXNZb2laS0RwUFNseTZTOV85VGktT3V6c2hHZFFUbi1Hald3TUxrVkZBckZhYW15N1FIWGhRWk1KWUR4cFQyLW9YTWQtMW1RXzEwRzVlQkMtRmVyYW04dU5oNXdmVTdRQzhNV0VGaFBHTHZqWjZoT0hxV2wzNVVxTFNGcXUtdWVMWHh4aHd4eXRqYmxB?oc=5) |
| FirstWord Pharma | Silence posts mid-stage polycythemia vera win, preps for Phase III | 2026-08-10 11:33 | [Source Link](https://news.google.com/rss/articles/CBMiU0FVX3lxTE1YODk4V2xmQVJwZlpFVHM4MWQ3TXlpTFdwaWZiSnpmUS1XdDBCdTBwV0tKSV81TWlYQkxwRm45dzk2SV91dkJRZW16WEZUWlZaWlVV?oc=5) |
| OncLive | Divesiran Meets Primary Response End Point in Phlebotomy-Dependent Polycythemia Vera | 2026-08-10 11:33 | [Source Link](https://news.google.com/rss/articles/CBMiswFBVV95cUxPSE1mV09DZGFyYTZQY19vNUNSTHFxS1MtQWNWR01HdUxRS01BLWUtUEtYaFJkM1pIQTluQjFCV3QyUUdzMVFZQXBNYWNEVi1vMFJfMW5vT01uZTAyRkVseWhQVGVyUXVtWUZ1VFhlZnlKY0tuRVNmVUVybDJ2RVFyYWpGcFU3VUwycEhxLXZCYVNSWEJyaGJoVDZTcEZlakhWTkhnZXhxS0FPWW5wYk1NR1g5WQ?oc=5) |
| Endpoints News | Silence spells out Phase 2 success for gene-silencing drug in rare blood cancer | 2026-08-10 11:33 | [Source Link](https://news.google.com/rss/articles/CBMipgFBVV95cUxNc1ZsV2lIM3U5bFZaTk9Ndlk0aWJWR2dNbEI4MG5xWjFwc1A3SXVNQWZ2Z2xGdUlnT0ZORDlBN1hPajNKcEE1bGhQXzA3bENKdHVWN1pZQl9TSWFSSTRHTXhpVE0tcEpOdmhhRnM3b3dXX1lhNEt0TDlaNmplSzR6YzczVTRIQjlvcnF0TS1EbzI5RmZ0MlRqVDNxVUJpeV9hRDFNNEJB?oc=5) |
| Fierce Biotech | Silence brings the noise to Takeda with phase 2 blood cancer win | 2026-08-10 11:33 | [Source Link](https://news.google.com/rss/articles/CBMilAFBVV95cUxOQXF5akhhMHFHSUVGQUJPM3RCYVdBcVJOSWtQUkg0a09BVWgzaU1tOXVLY3ZhRlduM2taZHFqNUNFZmRnQmxuS2hsbXZOdlhPVkljQzZESjV2OFpkTW1Cd1FVU0h0SFR6bUczRVBtX2pyOW1fYnBnZHJneGl0bFlaV3Z5Wm9ydWw2VGxiREs5amREUmxV?oc=5) |
| statnews.com | Silence Therapeutics aims at Takeda with new data in rare blood cancer | 2026-08-10 11:33 | [Source Link](https://news.google.com/rss/articles/CBMipwFBVV95cUxPdE4tNFB6VWwwUU1TNzBiamoyc3lNcjlvQUhBR0lLQTZoN2RjUW5BbFNubFZudFJQUWFGU1ZpTmQxclBWQW9RZDU3dzdhU3B2c2xOc2dXNUZnM1lKeGRjcWM4NGdoVW4xRjdOSHVzRkJEcmRRalNGYjdpc0RNamRCWnQ1WmFuTXNqd25hZTYybWZ3RGJtMFhGYmRUWHg2Snd2ZGNwWEZPOA?oc=5) |

---
*Canonical Source: https://www.newsylist.com/trend/2026-08-10/silence-therapeutics-aims-at-takeda-with-new-data-in-rare-blood-cancer*
*Synthesized by Newsylist Open Intelligence Engine under E-E-A-T journalistic standards.*